10月9日，凯莱英盘中下跌3.37%，报157.3港元，成交额295.21万港元。
消息面上，近期多家机构连续减持凯莱英H股，对市场情绪形成压制。摩根大通于9月23日以每股均价159.1287港元场外卖出8.32万股，好仓比例降至8.8%；施罗德于9月24日减持17.58万股，每股作价约150.23港元；南方基金此前亦减持2.51万股。机构密集调仓叠加节后避险情绪，导致股价承压。
公司基本面仍有亮点，在手订单16.73亿美元同比增长53.77%，化学大分子基地通过美国FDA批准前检查，但短期外资减持压力占据主导。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.